Evidence map›Paper›PMID 28759216›Full record

ArticleJournal of the American Chemical Society2017

Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.

Timothy M Acker, Jonathan E Gable, Markus-Frederik Bohn, Priyadarshini Jaishankar, Michael C Thompson, James S Fraser, Adam R Renslo, Charles S Craik

Abstract readComparative Study
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Antibody Reveals Conformational Latch Controlling Herpesvirus Proteases.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. High throughput and quantitative enzymology in the genomic era.Current opinion in structural biology · 2021
    Review
  6. Review
  7. Structure-Based Analysis of Cryptic-Site Opening.Structure (London, England : 1993) · 2020
    Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Timothy M AckerDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.
Jonathan E GableDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.
Markus-Frederik BohnDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.
Priyadarshini JaishankarDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.
Michael C ThompsonDepartment of Bioengineering and Therapeutic Sciences, University of California , San Francisco, California 94158, United States.
James S FraserDepartment of Bioengineering and Therapeutic Sciences, University of California , San Francisco, California 94158, United States.
Adam R RensloDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.ORCID 0000-0002-1240-2846
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.ORCID 0000-0001-7704-9185
University of California, San Francisco · US

Funding

X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2007 to 2018
$48.8M
STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Renewable antibodies to secreted proteins and single and multi-pass cell surfaceP41CA196276 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARKS, JAMES D. · 2014 to 2018
$5.8M
K777 for treatment of Chagas Disease: IND-enabling Studies and IND SubmissionR01AI090592 · NIAID · DRUGS FOR NEGLECTED DISEASES INITIATIVE · PI DON, ROBERT · 2010 to 2012
$1.2M
Allosteric Inhibition of a Family of Proteolytic EnzymesR01GM104659 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2013 to 2016
$1.2M
Development of Novel Human Herpes Virus InhibitorsF32GM111012 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACKER, TIMOTHY M · 2014 to 2016
$158k
NCI NIH HHS P41 CA196276NIAID NIH HHS R01 AI090592NIGMS NIH HHS F32 GM111012NIGMS NIH HHS P50 GM082250NIGMS NIH HHS R01 GM104659NIGMS NIH HHS T32 GM008284
6 · The paper itself

Abstract

Targeting of cryptic binding sites represents an attractive but underexplored approach to modulating protein function with small molecules. Using the dimeric protease (Pr) from Kaposi's sarcoma-associated herpesvirus (KSHV) as a model system, we sought to dissect a putative allosteric network linking a cryptic site at the dimerization interface to enzyme function. Five cryogenic X-ray structures were solved of the monomeric protease with allosteric inhibitors bound to the dimer interface site. Distinct coordinated movements captured by the allosteric inhibitors were also revealed as alternative states in room-temperature X-ray data and comparative analyses of other dimeric herpesvirus proteases. A two-step mechanism was elucidated through detailed kinetic analyses and suggests an enzyme isomerization model of inhibition. Finally, a representative allosteric inhibitor from this class was shown to be efficacious in a cellular model of viral infectivity. These studies reveal a coordinated dynamic network of atomic communication linking cryptic binding site occupancy and allosteric inactivation of KHSV Pr that can be exploited to target other members of this clinically relevant family of enzymes.

Indexed as

Allosteric RegulationCrystallography, X-RayHerpesviridae InfectionsHerpesvirus 8, HumanHumansModels, MolecularPeptide HydrolasesProtease InhibitorsProtein ConformationProtein MultimerizationPeptide HydrolasesProtease Inhibitors

Identifiers

PMID28759216
PMCPMC6089631
OpenAlexW2740096108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.